Abstract
Thrombocytopenia (TCP) often occurs after cardiac surgery. However, few data exist regarding the role of baseline and post-procedural TCP on early and late outcomes after transcatheter aortic valve replacement (TAVR). 714 patients undergoing TAVR from two heart hospitals were included in the study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.